These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1316417)

  • 1. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome.
    Linde A; Andersson B; Svenson SB; Ahrne H; Carlsson M; Forsberg P; Hugo H; Karstorp A; Lenkei R; Lindwall A
    J Infect Dis; 1992 Jun; 165(6):994-1000. PubMed ID: 1316417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of interferon gamma, interleukin-6 and neopterin in patients with infectious mononucleosis and other Epstein-Barr virus-related lymphoproliferative diseases.
    Schuster V; Herold M; Wachter H; Reibnegger G
    Infection; 1993; 21(4):210-3. PubMed ID: 8225623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis.
    Biglino A; Sinicco A; Forno B; Pollono AM; Sciandra M; Martini C; Pich P; Gioannini P
    Clin Immunol Immunopathol; 1996 Jan; 78(1):61-9. PubMed ID: 8599886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection.
    Bellmann-Weiler R; Schroecksnadel K; Holzer C; Larcher C; Fuchs D; Weiss G
    J Affect Disord; 2008 May; 108(1-2):171-6. PubMed ID: 17945348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and Fatigue.
    Fevang B; Wyller VBB; Mollnes TE; Pedersen M; Asprusten TT; Michelsen A; Ueland T; Otterdal K
    Front Immunol; 2021; 12():715102. PubMed ID: 34987499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
    Fark AR
    J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased levels of circulating IFN-alpha and increased sCD23 in patients with acute infectious mononucleosis.
    Prabhu A; Warwick M; Mathur A
    Viral Immunol; 1996; 9(1):45-50. PubMed ID: 8733919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ; McAulay KA; Anthony IC; Crawford DH
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulated cellular immune system in patients with congestive heart failure.
    Fuchs D; Samsonov M; Tilz GP; Reibnegger G; Belenkov JN; Nassonov EL; Wachter H
    Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):111-4. PubMed ID: 8490055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G; Straus S; Henle W; Pike SE; Blaese RM
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study.
    Pedersen M; Asprusten TT; Godang K; Leegaard TM; Osnes LT; Skovlund E; Tjade T; Øie MG; Wyller VBB
    Brain Behav Immun; 2019 Jan; 75():94-100. PubMed ID: 30261303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis.
    Vinante F; Morosato L; Siviero F; Nadali G; Rigo A; Veneri D; de Sabata D; Vincenzi C; Chilosi M; Semenzato G
    Haematologica; 1994; 79(5):413-9. PubMed ID: 7843627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo.
    Hornef MW; Wagner HJ; Kruse A; Kirchner H
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):209-13. PubMed ID: 7697531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome.
    Buchwald D; Wener MH; Pearlman T; Kith P
    J Rheumatol; 1997 Feb; 24(2):372-6. PubMed ID: 9034999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 lymphocytes during Epstein Barr virus (EBV) infection: A CD29 positive population is expanded in acute infectious mononucleosis.
    de Paoli P; Gennari D; Reitano M; Martelli P; Sacilotto C; Comoretto R; Santini G
    Allergol Immunopathol (Madr); 1991; 19(2):95-7. PubMed ID: 1722959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma delta T cell receptor-bearing lymphocytes during Epstein-Barr virus infection.
    De Paoli P; Gennari D; Martelli P; Cavarzerani V; Comoretto R; Santini G
    J Infect Dis; 1990 May; 161(5):1013-6. PubMed ID: 2324529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
    J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated lymphocytes during acute Epstein-Barr virus infection.
    Tomkinson BE; Wagner DK; Nelson DL; Sullivan JL
    J Immunol; 1987 Dec; 139(11):3802-7. PubMed ID: 3119718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Th1-type cytokine serum levels in patients with infectious mononucleosis.
    Corsi MM; Ruscica M; Passoni D; Scarmozzino MG; Gulletta E
    Acta Virol; 2004; 48(4):263-6. PubMed ID: 15745050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.